Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Pancreatic Cancer: Prospective Study

NCT06388967 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06388967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Pancreatic Cancer: Prospective Study
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2023
Completion date
December 30, 2030
Enrollment
2,000 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, pancreatic cancer, pancreatic cancer non-resectable, pancreatic cancer resectable, pancreatic cancer stage, pancreatic cancer stage 0, pancreatic cancer stage i, pancreatic cancer stage ii, pancreatic cancer stage iii, pancreatic cancer, adult, pancreatic carcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasms